Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
Research reports from Institute of Immunology provide new insights into immunotherapy in children
May 21st, 2008
Research findings, 'Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children,' are discussed in a new report. According to recent research from Zagreb, Croatia, "Recent evidence suggests that regulatory T cells (Treg cells) and immunosuppressive cytokines, such as transforming growth factor BETA1 (TGF-BETA1) and interleukin 10 (IL-10), may have a role in clinically effective allergen specific immunotherapy (SIT). To evaluate the effect of SIT on the induction of Treg cells in house dust mite-allergic children and on the expression of specific Treg cell markers (cytotoxic T-lymphocyte-associated protein 4 [CTLA-4], IL-10, and...
Source: Immunotherapy Weekly (2008-05-21)
|
